Anat Loewenstein

2 weeks ago | healio.com | Anat Loewenstein |Baruch D. Kuppermann |Michela Cimberle

SEVILLE, Spain — In this Healio Video Perspective, Anat Loewenstein, MD, MHA, and Baruch D. Kuppermann, MD, PhD, highlight topics discussed at the Congress on Controversies in Ophthalmology. “We’ve had a lot of interesting debates with great participation all around,” Kuppermann said. Basic research, emerging therapies, futuristic approaches and pragmatic management issues were addressed from different perspectives in the fields of retina, glaucoma, neuro-ophthalmology and uveitis.

1 month ago | ophthalmologytimes.com | Martin Friedlander |Anat Loewenstein |Mohammad Rafieetary |Sheryl Stevenson

The approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) as the first and only FDA-approved treatment for macular telangiectasia type 2 (MacTel) marks a significant milestone for patients with the progressive retinal disease.1 The implantable device uses encapsulated cell therapy (ECT) technology to continuously deliver therapeutic doses of ciliary neurotrophic factor (CNTF) to the retina, helping to slow disease progression.The approval was based on the results from...

2 months ago | europe.ophthalmologytimes.com | Sheryl Stevenson |Hattie Hayes |Anat Loewenstein

Following the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting, held virtually on February 8, 2025, Anat Loewenstein, MD, shared key takeaways from her presentation. Prof Loewenstein is Professor and Head of Retina, Division of Ophthalmology at Tel Aviv Medical Center, Sydney Fox Chair of Ophthalmology at Tel Aviv University, and President of the Israeli Ophthalmological Society, all in Tel Aviv, Israel.

2 months ago | ophthalmologytimes.com | Anat Loewenstein |Sheryl Stevenson

NewsVideoFebruary 17, 2025Author(s):,Examining the performance of AI algorithms versus human graders in neovascular age-related macular degenerationAnat Loewenstein, MD, shared key takeaways from a cross-sectional pivotal home OCT trial that compared the performance of AI-enabled algorithms with human expert graders in neovascular age-related macular degeneration during her presentation at the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting, held virtually on February 8, 2025.

Nov 5, 2024 | healio.com | Anat Loewenstein |Michela Cimberle |Christine Klimanskis

September 24, 2024 2 min watch VIDEO: Euretina president delivers overview of meeting Add topic to email alerts Please provide your email address to receive an email when new articles are posted on Retina/Vitreous in Ophthalmology. Subscribe Added to email alerts You've successfully added Retina/Vitreous in Ophthalmology to your alerts. You will receive an email when new content is published.